Wegovy prescription is dependent on the retail cost on the pharmacy. Currently Chemist Warehouse are retailing for $249 per pen at any dosage*

Wegovy and Ozempic are different brands for the same product, Semaglutide.

• Ozempic is Semaglutide 1.0mg licensed for type 2 diabetes.

• Wegovy is Semaglutide 2.4mg licensed for obesity.

Wegovy is indicated as an adjunct to a reduced-calorie diet and increased physical activity for chronic weight management (including weight loss and weight maintenance) in adults with an initial Body Mass Index (BMI) of

• a BMI of 30 kg/m² or greater (obesity),

• or a BMI of 27 kg/m² and less than 30 kg/m² (overweight) and weight-related health problems.

Like all medicines, Wegovy® has risks and benefits. The most common side effects include nausea, vomiting, constipation, and fatigue—especially at the beginning. Serious side effects are rare but will be discussed during your medical assessment.

For full details, see the Consumer Medicine Information (CMI) at www.medsafe.govt.nz or contact our team.

In clinical trials, patients using Wegovy® alongside healthy lifestyle changes lost significantly more weight than those using lifestyle changes alone. Results vary from person to person, and long-term commitment is key. If Wegovy is determined to be right for you, the health practitioner will discuss your unique plan with you.